Remove Clinical Trials Remove Conditions Remove Environment
article thumbnail

What A Surprise …Not. “TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions”

Cannabis Law Report

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “I agree with the committee that the preliminary findings from clinical trials — although still in early phases — evaluated by the panel are promising,” the decision’s author said.

article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Do you trust your doctor about cannabis?

The Cannigma

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. The respondents ranged in age from 19 to 81, and 50% identified as White, 20% as Latino, 12% as Asian, and 10% as Black.

Education 105
article thumbnail

Trouble Sleeping: Cannabis for Insomnia Relief

MMJ Recs

It can be caused by a variety of factors, including medical conditions, psychological issues, or environmental factors. It can be caused by underlying health conditions, medications, or psychological factors. Comorbid Insomnia : Also known as secondary insomnia, it occurs alongside another medical or psychiatric condition.

Sleep 111
article thumbnail

UK: Assoc For The Cannabinoid Industry Founder Says UK World’s Biggest Market After The US

Cannabis Law Report

Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. ” Despite those concerns, Joe Oliver, head of British-based cannabidiol firm LDN CBD, says his products help those with chronic illness. .

article thumbnail

Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors

Cannabis Law Report

This press release contains forward-looking statements, including statements regarding our product development, business strategy, timing of clinical trials and commercialization of cannabinoid-derived therapeutics. We operate in a rapidly changing environment and new risks emerge from time to time. FORWARD LOOKING STATEMENTS.

article thumbnail

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

Eurofins is a global leader in food, environment, and pharmaceutical product testing. It is also one of the market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing.